101
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Investigation of alanine mutations affecting insulin-like growth factor (IGF) I binding to IGF binding proteins

, , &
Pages 40-49 | Received 06 May 2014, Accepted 09 Sep 2014, Published online: 26 Sep 2014

References

  • Bach LA, Headey SJ, Norton RS. 2005. IGF-binding proteins-the pieces are falling into place. Trends Endocrinol Metab 16:228–234
  • Barducci A, Bonomi M, Prakash MK, Parrinello M. 2013. Free-energy landscape of protein oligomerization from atomistic simulations. Proc Natl Acad Sci USA 110:E4708–E4713
  • Baxter RC. 2000. Insulin-like growth factor (IGF)-binding proteins: Interactions with IGFs and intrinsic bioactivities. Am J Physiol-Endoc M 278:E967–E976
  • Bayne ML, Applebaum J, Chicchi GG, Hayes NS, Green BG, Cascieri MA. 1988. Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor. J Biol Chem 263:6233–6239
  • Bayne ML, Applebaum J, Chicchi GG, Miller RE, Cascieri MA. 1990. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor. J Biol Chem 265:15648–15652
  • Beisel HG, Kamionka MK, Kalus W, Engh RA, Huber R, Lang K, Holak TA. 2001. The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5. EMBO J 20:3638–3644
  • Buckway CK, Wilson EM, Ahlsén M, Bang P, OH Y, Rosenfeld RG. 2001. Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding. J Clin Endocrinol Metab 86:4943–4950
  • Carrick FE, Forbes BE, Wallace JC. 2001. BIAcore analysis of bovine insulin-like growth factor (IGF)-binding protein-2 identifies major IGF binding site determinants in both the amino- and carboxyl-terminal domains. J Biol Chem 276:27120–27128
  • Carrick FE, Wallace JC, Forbes BE. 2002. The interaction of insulin-like growth factors (IGFs) with insulin-like growth factor binding proteins (IGFBPs): A review. Lett Pept Sci 8:147–153
  • Carrick FE, Hinds MG, McNeil KA, Wallace JC, Forbes BE, Norton RS. 2005. Interaction of insulin-like growth factor (IGF)-I and –II with IGF binding protein-2: Mapping the binding surfaces by nuclear magnetic resonance. J Mol Endocrinol 34:685–698
  • Cascieri MA, Chicchi GC, Applebaum J, Hazes NS, Green BC, Bayne ML. 1988. Mutants of human insulin-like growth factor I with reduced affinity for the type I insulin-like growth factor receptor. Biochemistry 27:3229–3233
  • Chen X, Duan D, Zhu S, Zhang J. 2013a. Molecular dynamics simulation of temperature induced unfolding of animal prion protein. J Mol Model 19:4433–4441
  • Chen X, Wu T, Wang Q, Shen J. 2008. Shield effect of silicate on adsorption of proteins onto silicon-doped hydroxyapatite (100) surface. Biomaterials 29:2423–2432
  • Chen X, Zhu S, Duan D, Wu T, Wang Q. 2013b. Investigation of the binding network of IGF-I on the cavity surface of IGFBP4. J Mol Model 19:5257–5266
  • Chiu C, Dieckmann GR, Nielsen SO. 2008. Molecular dynamics study of a nanotube-binding amphiphilic helical peptide at different water/hydrophobic interfaces. J Phys Chem B 112:16326–16333
  • Clemmons DR, Cascieri MA, Camacho-Hubner C, McCusker RH, Bayne ML. 1990. Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity. J Biol Chem 265:12210–12216
  • Clemmons DR. 2001. Use of mutagenesis to probe IGF-binding protein structure/function relationships. Endocr Rev 22:800–817
  • Dubaquie Y, Mortensen DL, Intintoli A, Hogue DA, Nakamura G, Rancatore P, Lester P, et al. 2001. Binding protein-3 selective insulin-like growth factor I variants: Engineering, biodistributions, and clearance. Endocrinology 142:165–173
  • Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824–854
  • Guo CC, Lu HB, Gao W, Wang L, Lu KH, Wu SH, Pataer A, et al. 2013. Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival. PLOS ONE 8:e74973
  • Hashimoto R, Ono M, Fujiwara H, Higashihashi N, Yoshida M, EnjohKimura T, Sakano K. 1997. Binding sites and binding properties of binary and ternary complexes of insulin-like growth factor-II (IGF-II), IGF-binding protein-3, and acid-labile subunit. J Biol Chem 272:27936–27942
  • Headey SJ, Keizer DW, Yao S, Brasier G, Kantharidis P, Bach LA, Norton RS. 2004. C-terminal domain of Insulin-like growth factor (IGF) binding protein-6: Structure and interaction with IGF-II. Mol Endocrinol 18:2740–2750
  • Horney MJ, Evangelista CA, Rosenzweig SA. 2001. Synthesis and characterization of insulin-like growth factor (IGF)-I photoprobes selective for the IGF-binding proteins (IGFBPS). Photoaffinity labeling of the IGF-binding domain on IGFBP-2. J Biol Chem 276:2880–2889
  • Humphrey W, Dalke A, Schulten K. 1996. VMD: Visual molecular dynamics. J Mol Graph Model 14:33–38
  • Hwa V, Oh Y, Rosenfeld RG. 1999. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20:761–787
  • Imai Y, Moralez A, Andag U, Clarke JB, Busby WH Jr, Clemmons DR. 2000. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J Biol Chem 275:18188–18194
  • Jansson M, Uhlen M, Nilsson B. 1997. Structural changes in Insulin-like Growth Factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor. Biochemistry 36:4108–4117
  • Jansson M, Andersson G, Uhlen M, Nilsson B, Kordel J. 1998. The insulin-like growth factor (IGF) binding protein 1 binding epitope on IGF-I probed by heteronuclear NMR spectroscopy and mutational analysis. J Biol Chem 273:24701–24707
  • Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. 1983. Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935
  • Kale L, Skeel R, Bhandarkar M, Brunner R, Gursoy A, Krawetz N, Phillips J, et al. 1999. NAMD2: Greater scalability for parallel molecular dynamics. J Comput Phys 151:283–312
  • Klaus W, Zweckstetter M, Renner C, Sanchez Y, Georgescu J, Grol M, Demuth D, et al. 1998. Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP5): Implications for IGF and IGF-I receptor interactions. EMBO J 17:6558–6572
  • Li MH, Zheng WJ. 2011. Probing the structural and energetic basis of kinesin- microtubule binding using computational alanine-scanning mutagenesis. Biochemistry 50:8645–8655
  • MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, Fischer S, et al. 1998. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102:3586–3616
  • Magee BA, Shooter GK, Wallace JC, Francis GL. 1999. Insulin-like growth factor I and its binding proteins: A study of the binding interface using B-domain analogues. Biochemistry 38:15863–15870
  • Moreira IS, Fernandes PA, Ramos MJ. 2007. Computational alanine scanning mutagenesis-An improved methodological approach. J Comput Chem 28:644–654
  • Noskov SY, Rostovtseva TK, Bezrukov SM. 2013. ATP transport through VDAC and the VDAC-Tubulin complex probed by equilibrium and nonequilibrium MD simulations. Biochemistry 52:9246–9256
  • Qin XZ, Strong DD, Baylink DJ, Mohan S. 1998. Structure-function analysis of the human insulin-like growth factor binding protein-4. J Biol Chem 273:23509–23516
  • Shand JH, Beattie J, Song H, Phillips K, Kelly SM, Flint DJ, Allan GJ. 2003. Specific amino acid substitutions determine the differential contribution of the N- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding (IGF)-I. J Biol Chem 278:17859–17866
  • Shen J, Wu T, Wang Q, Pan H. 2008. Molecular simulation of protein adsorption and desorption on hydroxyapatite surface. Biomaterials 29:513–532
  • Shooter GK, Magee B, Soos MA, Francis GL, Siddle K, Wallace JC. 1996. Insulin-like growth factor (IGF)-I A- and B-domain analogues with altered type 1 IGF and insulin receptor binding specificities. J Mol Endocrinol 17:237–246
  • Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA. 2006. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Pro Natl Acad Sci USA 103:13028–13033
  • Siwanowicz I, Popowicz GM, Wisniewska M, Huber R, Kuenkele KP, Lang K, Engh RA, Holak TA. 2005. Structural basis for the regulation of insulin-like growth factors by IGF binding proteins. Structure 13:155–167
  • Skolnick J, Fetrow JS, Kolinski A. 2000. Structural genomics and its importance for gene function analysis. Nat Biotechnol 18:283–287
  • Yan X, Forbes BE, McNeil KA, Baxter RC, Firth SM. 2004. Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation. J Biol Chem 279:53232–53240
  • Zoete V, Meuwly M, Karplus M. 2005. Study of the insulin dimerization: Binding free energy calculations and per-residue free energy decomposition. Proteins 61:79–93
  • Żeslawski W, Beisel HG, Kamionka M, Kalus W, Engh RA, Huber R, Lang K, Holak TA. 2001. The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5. EMBO J 20:3638–3644

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.